U.S. FDA advisers overwhelmingly back Moderna COVID vaccine for ages 6-17
June 14 (Reuters) - Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc's (MRNA.O) COVID-19 vaccine for children and teens aged 6 to 17 years of age.Around 77 million…